Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Gastrointestinal Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00995358
What this trial is testing

A Study With Peptide Vaccination in Treating Patients With Esophageal Cancer

Who this might be right for
Esophageal Cancer
University of Yamanashi 60
Testing effectiveness (Phase 2)Ended earlyNCT01834235
What this trial is testing

QUILT-3.010: A Study of Gemcitabine and Nab-paclitaxel With or Without NPC-1C to Treat Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer, Adult
Precision Biologics, Inc 81
Not applicableUnknownNCT03896958
What this trial is testing

The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)

Who this might be right for
Cancer, All TypesCancer of LiverCancer of Stomach+42 more
SpeciCare 1,000
Not applicableLooking for participantsNCT01479608
What this trial is testing

Liver Transplantation and Colorectal Cancer

Who this might be right for
Colorectal CancerLiver Metastasis
Oslo University Hospital 25
Not applicableNot Yet RecruitingNCT07768085
What this trial is testing

Pragmatic RCT of AI-Assisted Reading for Malignant Hepatic Lesions on CE-CT

Who this might be right for
Hepatocellular Carcinoma (HCC)Intrahepatic Cholangiocarcinoma (Icc)Hepatic Metastasis+3 more
Shengjing Hospital 40,000
Early research (Phase 1)Study completedNCT00379132
What this trial is testing

131-I-TM-601 Study in Adults With Solid Tumors

Who this might be right for
Breast CancerNon-Small Cell Lung CancerMelanoma+5 more
TransMolecular 60
Not applicableUnknownNCT05242237
What this trial is testing

Prognostic Value of Liver Cancer CTCs Isolated by a Novel Microfluidic Platform

Who this might be right for
Hepatocellular CarcinomaCirculating Tumor CellWhole Genome Sequencing
The Second Affiliated Hospital of Chongqing Medical University 300
Testing effectiveness (Phase 2)WithdrawnNCT00620607
What this trial is testing

HuC242-DM4 Treating Patients With Metastatic Gastric or Gastroesophageal Junction Carcinomas

Who this might be right for
Stomach NeoplasmsMetastatic or Locally Advanced Gastric CancerMetastatic or Local Advanced GE Junction Cancer
ImmunoGen, Inc.
Not applicableUnknownNCT03356236
What this trial is testing

Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma Following Local Ablation

Who this might be right for
Hepatocarcinoma
Yue Han 828
Early research (Phase 1)Study completedNCT03095781
What this trial is testing

Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer

Who this might be right for
Colorectal AdenocarcinomaMetastatic Pancreatic AdenocarcinomaRecurrent Colorectal Carcinoma+12 more
Emory University 47
Testing effectiveness (Phase 2)Study completedNCT00095992
What this trial is testing

SB-715992 in Treating Patients With Locally Advanced, Recurrent, or Metastatic Liver Cancer

Who this might be right for
Liver Cancer
NCIC Clinical Trials Group 15
Testing effectiveness (Phase 2)Ended earlyNCT02575339
What this trial is testing

MLN0128 Compared to Sorafenib in Advanced or Metastatic Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver CancerHCC
Kathy Miller 11
Post-approval studies (Phase 4)Not Yet RecruitingNCT07829757
What this trial is testing

Zolbetuximab Given With mFOLFOX6 or CAPOX Chemotherapy in Indian Adults With Gastric Cancer

Who this might be right for
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or CancerLocally Advanced Unresectable Gastric Adenocarcinoma or CancerMetastatic Gastric Adenocarcinoma or Cancer+1 more
Astellas Pharma Global Development, Inc.
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07692334
What this trial is testing

Becotatugvedotin Plus Pucotenlimab in EGFR-Positive Advanced Gastric/GEJ Adenocarcinoma

Who this might be right for
Gastric CancerGastroesophageal Junction (GEJ) AdenocarcinomaBecotatug Vedotin+1 more
West China Second University Hospital 28
Testing effectiveness (Phase 2)Study completedNCT03190265
What this trial is testing

Study of CRS-207, Nivolumab, and Ipilimumab With or Without GVAX Pancreas Vaccine (With Cy) in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 61
Large-scale testing (Phase 3)Active Not RecruitingNCT04704934
What this trial is testing

Trastuzumab Deruxtecan for Subjects With HER2-Positive Gastric Cancer or Gastro-Esophageal Junction Adenocarcinoma After Progression on or After a Trastuzumab-Containing Regimen (DESTINY-Gastric04)

Who this might be right for
Gastric Cancer, AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Daiichi Sankyo 490
Testing effectiveness (Phase 2)Active Not RecruitingNCT04543071
What this trial is testing

Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic CancerAdenocarcinoma of the PancreasAdenocarcinoma
Columbia University 118
Testing effectiveness (Phase 2)Ended earlyNCT01248299
What this trial is testing

Benefit of Chemotherapy Over Best Supportive Care in Metastatic and Squamous Cell-type Esophageal Cancer.

Who this might be right for
Squamous Cell Carcinoma of Esophagus
Centre Oscar Lambret 105
Testing effectiveness (Phase 2)Active Not RecruitingNCT06105021
What this trial is testing

Phase I Study of Autologous CD8+ and CD4+ Engineered T Cell Receptor T Cells in Subjects With Advanced or Metastatic Solid Tumor

Who this might be right for
Pancreatic Ductal AdenocarcinomaNon-Small Cell Lung CancerColorectal Cancer+2 more
Affini-T Therapeutics, Inc. 100
Testing effectiveness (Phase 2)Study completedNCT00560963
What this trial is testing

Treatment of Patients Suffering From a Progressive Pancreas Carcinoma With Everolimus (RAD001) and Gemcitabine

Who this might be right for
Advanced or Metastatic Pancreatic Adenocarcinoma
Novartis Pharmaceuticals 21
Next Page
50